Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Psychiatry (Edgmont (Pa. : Township))
|
June 10, 2010
Lisdexamfetamine dimesylate: the first prodrug stimulant
David W Goodman
Therapeutics and Clinical Risk Management
|
April 12, 2013
Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studies
David W Goodman
Evidence-Based Mental Health
|
May 25, 2013
Artificial food colour exclusion and free fatty acid supplementation may reduce symptom severity in children with ADHD
David W Goodman
Journal of Psychiatric Practice
|
September 25, 2007
The consequences of attention-deficit/hyperactivity disorder in adults
David W Goodman
P & T : a Peer-Reviewed Journal for Formulary Management
|
June 2, 2010
Lisdexamfetamine dimesylate (vyvanse), a prodrug stimulant for attention-deficit/hyperactivity disorder
David W Goodman
The Primary Care Companion for CNS Disorders
|
December 2, 2016
Adult Attention-Deficit/Hyperactivity Disorder Diagnosis, Management, and Treatment in the DSM-5 Era
Joel L Young, David W Goodman
Postgraduate Medicine
|
October 13, 2009
Recognizing ADHD in adults with comorbid mood disorders: implications for identification and management
David W Goodman, Michael E Thase
Attention Deficit and Hyperactivity Disorders
|
January 27, 2017
Is ADHD a valid diagnosis in older adults?
Craig B H Surman, David W Goodman
Expert Review of Neurotherapeutics
|
August 5, 2024
Why is ADHD so difficult to diagnose in older adults?
David W Goodman, Samuele Cortese, Stephen V Faraone
Drugs & Aging
|
December 15, 2015
Clinical Presentation, Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Older Adults: A Review of the Evidence and its Implications for Clinical Care
David W Goodman, Sara Mitchell, Lauren Rhodewalt, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Psychiatry (Edgmont (Pa. : Township))
|
June 10, 2010
Lisdexamfetamine dimesylate: the first prodrug stimulant
David W Goodman
Therapeutics and Clinical Risk Management
|
April 12, 2013
Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studies
David W Goodman
Evidence-Based Mental Health
|
May 25, 2013
Artificial food colour exclusion and free fatty acid supplementation may reduce symptom severity in children with ADHD
David W Goodman
Journal of Psychiatric Practice
|
September 25, 2007
The consequences of attention-deficit/hyperactivity disorder in adults
David W Goodman
P & T : a Peer-Reviewed Journal for Formulary Management
|
June 2, 2010
Lisdexamfetamine dimesylate (vyvanse), a prodrug stimulant for attention-deficit/hyperactivity disorder
David W Goodman
The Primary Care Companion for CNS Disorders
|
December 2, 2016
Adult Attention-Deficit/Hyperactivity Disorder Diagnosis, Management, and Treatment in the DSM-5 Era
Joel L Young, David W Goodman
Postgraduate Medicine
|
October 13, 2009
Recognizing ADHD in adults with comorbid mood disorders: implications for identification and management
David W Goodman, Michael E Thase
Attention Deficit and Hyperactivity Disorders
|
January 27, 2017
Is ADHD a valid diagnosis in older adults?
Craig B H Surman, David W Goodman
Expert Review of Neurotherapeutics
|
August 5, 2024
Why is ADHD so difficult to diagnose in older adults?
David W Goodman, Samuele Cortese, Stephen V Faraone
Drugs & Aging
|
December 15, 2015
Clinical Presentation, Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Older Adults: A Review of the Evidence and its Implications for Clinical Care
David W Goodman, Sara Mitchell, Lauren Rhodewalt, et al.
Page
of 4